Pune, India -- (SBWIRE) -- 01/15/2018 -- The Global Liquid Biopsy Market accounted to USD 650.0 million in 2016 growing at a CAGR of 21.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Also the Global Liquid Biopsy Market, By Product (Instruments, Software), Cancer Type (Lung, Breast, Colorectal, Prostate, Liver), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA), End User (Hospitals, Laboratories, Research Centers), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024.

The liquid biopsy is a non invasive technique which is used to test blood in order to detect circulating tumor cells.

Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-liquid-biopsy-market            

Global Liquid Biopsy Market – Major market drivers and restraints:


- Benefits offered by liquid biopsies over solid tissue biopsy methods

- Rise in prevalence of cancer

- Rise in awareness about minimally invasive methods

- Reimbursement & regulation scenario would hamper the growth


Global Liquid Biopsy Market Segmentation:

On the basis of product, the global liquid biopsy market is segmented into instruments and software.

By cancer type, the global liquid biopsy market is segmented into lung, breast, colorectal, prostate and liver.

By circulating biomarkers, the global liquid biopsy market is segmented into circulating tumor cells and circulating tumor DNA.

On the basis of end user, the global liquid biopsy market is segmented into hospitals, laboratories, and research centers.

On the basis of geography, global liquid biopsy market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Have Any Query? Ask Ours Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-liquid-biopsy-market                     

Global Liquid Biopsy Market – Competitive Analysis:

Global liquid biopsy market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of liquid biopsy market for global, Europe, North America, Asia Pacific and South America.

Global Liquid Biopsy Market – Major Market Competitors:

Some of the major players operating in global liquid biopsy market are BIOCEPT, INC., QIAGEN, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc., Myriad Genetics, Inc., Janssen Global Services, LLC, Trovagene, GUARDANT HEALTH, INC, Grail, Inc, Fraunhofer-Gesellschaft, RainDance Technologies, Inc., Adaptive Biotechnologies, NeoGenomics Laboratories, Inc., Guardant Health, and Cynvenio Biosystems, Inc., among others.

Read More Information of This Report…Follow Link @ http://databridgemarketresearch.com/reports/global-liquid-biopsy-market/